DATROWAY® (datopotamab deruxtecan-dlnk) approved in the …
1 day ago · DATROWAY is the eighth new medicine of the 20 AstraZeneca has set out to deliver by 2030 DATROWAY ® (datopotamab deruxtecan-dlnk) has been approved in the US for the …
DATROWAY® Approved in the U.S. for Patients with Previously …
1 day ago · Daiichi Sankyo and AstraZeneca are committed to ensuring that patients in the U.S. who are prescribed DATROWAY can access the medication and receive necessary financial …
Datroway (datopotamab deruxtecan) approved in the US for …
1 day ago · In the Datroway arm, the interstitial lung disease (ILD) rate was 4.2% and the majority of events were low grade. Datroway is a specifically engineered TROP2-directed antibody …
DATROWAY® (datopotamab deruxtecan-dlnk) approved in the …
14 hours ago · First approval in the US for AstraZeneca and Daiichi Sankyo’s DATROWAY based on TROPION-Breast01 results showing 37% reduction in the risk of disease progression or …
DATROWAY® Approved in the U.S. for Patients with Previously …
14 hours ago · DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed by …
DATROWAY® Approved in the U.S. for Patients with
1 day ago · DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed by …
DATROWAY® (datopotamab deruxtecan-dlnk) approved in the
1 day ago · DATROWAY is a specifically engineered TROP2-directed antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by AstraZeneca and Daiichi …
DATROWAY® (datopotamab deruxtecan-dlnk) approved in the …
1 day ago · DATROWAY is a specifically engineered TROP2-directed antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by AstraZeneca and Daiichi …
AstraZeneca, Daiichi Win FDA Approval for Breast Cancer Drug
16 hours ago · AstraZeneca Plc and Daiichi Sankyo Co. won US approval for a novel breast cancer treatment, a milestone in the companies’ efforts to turn the medicine into a widely used …
AstraZeneca’s Datroway approved in U.S. for HER2-negative …
11 hours ago · AstraZeneca price target raised to 13,100 GBp from 12,600 GBp at Guggenheim; AstraZeneca’s Calquence combination approved in U.S. Drugmakers to push Trump to pause …
- Some results have been removed